mopidamol has been researched along with Adenocarcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cornell, CJ; Forcier, RJ; Forman, WB; Henderson, WG; Martin, JF; Rickles, FR; Van Eeckhout, JP; Zacharski, LR | 1 |
| Ambrus, CM; Ambrus, JL; Gastpar, H | 1 |
| Gallick, GE; Lichtner, RB; Nicolson, GL | 1 |
| Lichtner, RB; Nicolson, GL | 1 |
1 review(s) available for mopidamol and Adenocarcinoma
| Article | Year |
|---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
1 trial(s) available for mopidamol and Adenocarcinoma
| Article | Year |
|---|---|
Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
Topics: Adenocarcinoma; Animals; Anticoagulants; Blood Platelets; Carcinoma, Small Cell; Clinical Trials as Topic; Colonic Neoplasms; Double-Blind Method; Humans; Lung Neoplasms; Mopidamol; Neoplasms; Neoplasms, Experimental; Pyrimidines; Random Allocation | 1982 |
3 other study(ies) available for mopidamol and Adenocarcinoma
| Article | Year |
|---|---|
Effect of phosphodiesterase inhibitors on platelet aggregation and tumor metastasis.
Topics: Adenocarcinoma; Adenosine Diphosphate; Animals; Carcinoma, Ehrlich Tumor; Female; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Macaca; Male; Mice; Mopidamol; Neoplasm Metastasis; Pentoxifylline; Platelet Aggregation; Rats; Theobromine; Wilms Tumor | 1981 |
Pyrimido-pyrimidine modulation of EGF growth-promoting activity and p21ras expression in rat mammary adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Cell Division; Epidermal Growth Factor; Mammary Neoplasms, Experimental; Mopidamol; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyrimidines; Rats | 1988 |
The pyrimido-pyrimidine derivatives RA 233 and RX-RA 85 affect growth and cytoskeletal organization of rat mammary adenocarcinoma cells.
Topics: Actin Cytoskeleton; Adenocarcinoma; Animals; Cell Line; Cell Survival; Cytoskeleton; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Microtubules; Mopidamol; Phosphodiesterase Inhibitors; Pyrimidines; Rats; Vacuoles | 1987 |